Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.020
-0.005 (-0.25%)
At close: Aug 29, 2025, 4:00 PM
2.040
+0.020 (0.99%)
After-hours: Aug 29, 2025, 7:49 PM EDT

Daré Bioscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
-0.020.012.8110--
Upgrade
Revenue Growth (YoY)
--99.65%-71.92%---
Upgrade
Cost of Revenue
14.314.3121.6430.140.10.08
Upgrade
Gross Profit
-14.32-14.3-18.83-20.14-0.1-0.08
Upgrade
Selling, General & Admin
8.729.1611.9111.248.356.55
Upgrade
Research & Development
-4.56---30.6220.77
Upgrade
Operating Expenses
4.169.1611.9111.2438.9727.32
Upgrade
Operating Income
-18.48-23.45-30.74-31.39-39.07-27.4
Upgrade
Other Non Operating Income (Expenses)
-0.7319.40.780.4400
Upgrade
EBT Excluding Unusual Items
-19.2-4.05-29.96-30.95-39.07-27.4
Upgrade
Other Unusual Items
---0.4-0.37-
Upgrade
Pretax Income
-18.6-4.05-30.16-30.95-38.7-27.4
Upgrade
Net Income
-18.6-4.05-30.16-30.95-38.7-27.4
Upgrade
Preferred Dividends & Other Adjustments
-----0.01
Upgrade
Net Income to Common
-18.6-4.05-30.16-30.95-38.7-27.41
Upgrade
Shares Outstanding (Basic)
987753
Upgrade
Shares Outstanding (Diluted)
987753
Upgrade
Shares Change (YoY)
10.12%16.80%3.23%38.29%103.23%93.16%
Upgrade
EPS (Basic)
-2.14-0.48-4.15-4.39-7.59-10.93
Upgrade
EPS (Diluted)
-2.14-0.48-4.15-4.39-7.59-10.93
Upgrade
Free Cash Flow
-11.874.82-39.49-18.15-28.78-25.25
Upgrade
Free Cash Flow Per Share
-1.370.57-5.43-2.58-5.65-10.07
Upgrade
Gross Margin
----201.42%--
Upgrade
Operating Margin
--239692.20%-1094.77%-313.86%--
Upgrade
Profit Margin
--41430.90%-1074.17%-309.48%--
Upgrade
Free Cash Flow Margin
-49276.38%-1406.26%-181.52%--
Upgrade
EBITDA
-17.84-23.41-30.7-31.36-39.04-27.36
Upgrade
D&A For EBITDA
0.630.040.040.020.030.04
Upgrade
EBIT
-18.48-23.45-30.74-31.39-39.07-27.4
Upgrade
Revenue as Reported
-0.012.8110--
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q